Tag: Pharma
IPA’s 10th Global Pharmaceutical Quality Summit 2025: Experts call for nurturing...
The two-day Summit witnessed 11 sessions and 50+ speakers, including industry leaders, government officials, global regulators, and quality experts
India’s pharma & healthcare sectors eye 30-40% productivity gains with GenAI...
GenAI is accelerating clinical operations, revenue cycle management, and patient experience in healthcare
Zydus & Beihai Biotech sign an exclusive deal to commercialize BEIZRAY...
Beihai Biotech shall receive upfront payments, sales targets-based milestone payments and a share of BEIZRAY’s net profits earned in the US as per the terms of the agreement
Orchid Pharma registers 26% PAT in Q3 of FY25
Q3 results show strong momentum in YoY-9 month backed by expansion of its anti-microbial portfolio
NPPA fixed ceiling prices of 131 scheduled anticancer formulations under NLEM:...
The National Pharmaceutical Pricing Authority has also fixed retail prices of 28 anti-cancer formulations of applicant manufacturing and marketing companies, under the DPCO, 2013 provisions relating to fixing of retail prices of new drugs
Emcure Pharma registers 18% revenue growth, 30% PAT in Q3 of...
Revenue from operations at Rs 1,963 Cr, up 17.7% YoY and PAT at 156Cr, up 30.3% YoY
Govt withdraws Track & Trace System provisions for pharma exports
DGFT streamlines export regulations in alignment with Ministry of Health & Family Welfare regulatory framework
Budget 2025: OPPI hails initiatives for inclusive & innovation-driven healthcare landscape
Anil Matai, Director General, OPPI expresses commitment towards working alongside policymakers to further strengthen the sector and address areas that require continued attention
Strides Pharma debuts with a stellar ESG rating of 76/100 in...
With this achievement, Strides has secured a position in the 94th percentile among its peers in the DRG Global Pharmaceuticals industry
Zydus Lifesciences receives approval from USFDA to conduct Phase II(b) clinical...
Usnoflast is a novel oral NLRP3 inflammasome inhibitor in patients with Amyotrophic Lateral Sclerosis (ALS)